Cardiac Tissue Engineering for the Treatment of Myocardial Infarction
Poor cell engraftment rate is one of the primary factors limiting the effectiveness of cell transfer therapy for cardiac repair. Recent studies have shown that the combination of cell-based therapy and tissue engineering technology can improve stem cell engraftment and promote the therapeutic effect...
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI AG
2021-11-01
|
| Cyfres: | Journal of Cardiovascular Development and Disease |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.mdpi.com/2308-3425/8/11/153 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|